Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera

Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage called B.1.1.7 (variant of concern: VOC 202012/01), which is reported to spread more efficiently and faster than other strains, emerged in the United Kingdom. This variant has an unusually large number of mutations,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Science (American Association for the Advancement of Science) Jg. 371; H. 6534; S. 1152
Hauptverfasser:	Muik, Alexander, Wallisch, Ann-Kathrin, Sänger, Bianca, Swanson, Kena A, Mühl, Julia, Chen, Wei, Cai, Hui, Maurus, Daniel, Sarkar, Ritu, Türeci, Özlem, Dormitzer, Philip R, Şahin, Uğur
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 12.03.2021
Schlagworte:	Adult Aged Antibodies, Neutralizing - blood Antibodies, Viral - blood China COVID-19 - blood COVID-19 - prevention & control COVID-19 - virology COVID-19 Vaccines - immunology Female Humans Male Middle Aged Neutralization Tests SARS-CoV-2 - genetics SARS-CoV-2 - immunology Spike Glycoprotein, Coronavirus - genetics Spike Glycoprotein, Coronavirus - immunology United Kingdom Young Adult United Kingdom China
ISSN:	1095-9203, 1095-9203
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!